Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-27 Sale | 2023-01-31 4:22 pm | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 1,358 | $20.26 | $27,513 | 75,339 (Direct) | View |
| 2023-01-09 Sale | 2023-01-09 5:09 pm | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 1,183 | $20.2 | $23,897 | 76,697 (Direct) | View |
| 2023-01-05 Sale | 2023-01-05 4:52 pm | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 5,029 | $20.2 | $101,586 | 77,880 (Direct) | View |
| 2022-07-14 Sale | 2022-07-15 4:03 pm | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 2,246 | $11.11 | $24,953 | 82,909 (Direct) | View |
| 2022-01-27 Sale | 2022-01-27 4:03 pm | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 1,995 | $26.15 | $52,169 | 78,488 (Direct) | View |
| 2022-01-10 Sale | 2022-01-12 4:29 pm | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 1,058 | $30.49 | $32,258 | 80,483 (Direct) | View |
| 2021-09-16 Purchase | 2021-09-16 4:12 pm | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 100 | $23.44 | $2,344 | 5,100 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-21 Option Award | 2023-06-23 5:53 pm | N/A 2033-06-20 | Mind Medicine (MindMed) Inc. | MNMD | CRYSTAL ROGER Director | 32,874 | $0 | 46,890 (Direct) | View |
| 2023-03-02 Disposition | 2023-03-03 09:18 am | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 87,106 | $20 | 0 (Direct) | View |
| 2023-03-02 Disposition | 2023-03-03 09:18 am | 2013-12-31 2023-12-30 | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 646,700 | $0 | 0 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-03 09:18 am | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 6,667 | $0 | 0 (Direct) | View |
| 2022-08-11 Option Award | 2022-08-15 9:55 pm | N/A 2032-08-10 | Mind Medicine (MindMed) Inc. | MNMD | CRYSTAL ROGER Director | 714,027 | $0 | 714,027 (Direct) | View |
| 2022-06-27 Option Award | 2022-06-29 4:06 pm | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 6,667 | $0 | 85,155 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-05 4:15 pm | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 40,000 | $0 | 81,541 (Direct) | View |
| 2021-01-26 Option Award | 2021-01-27 4:23 pm | N/A 2031-01-26 | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 50,666 | $0 | 72,791 (Direct) | View |
| 2020-01-07 Option Award | 2020-01-09 4:07 pm | N/A 2030-01-07 | OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner | 40,900 | $0 | 49,375 (Direct) | View |